BHE
Benchmark Electronics, Inc. · Technology · Electronic Components
Last
$57.81
−$1.37 (−2.31%) 4:00 PM ET
After hours $57.81 −$0.00 (−0.01%) 9:03 PM ET
Prev close $59.18
Open $58.57
Day high $58.57
Day low $57.15
Volume 434,673
Avg vol 297,932
Mkt cap
$2.06B
P/E ratio
85.02
FY Revenue
$2.66B
EPS
0.68
Gross Margin
10.16%
Sector
Technology
AI report sections
BHE
Benchmark Electronics, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+98% (Above avg)
Vol/Avg: 1.98×
RSI
65.84 (Strong)
Strong (60–70)
MACD momentum
Intraday
+0.04 (Strong)
MACD: 0.11 Signal: 0.07
Short-Term
-0.16 (Weak)
MACD: 2.43 Signal: 2.58
Long-Term
+0.10 (Strong)
MACD: 4.04 Signal: 3.94
Intraday trend score 54.00

Latest news

BHE 9 articles Positive: 2 Neutral: 2 Negative: 0
Positive GlobeNewswire Inc. • Sns Insider
Contract Manufacturing & Design Services Market Size to Hit USD 1441.89 Billion by 2032, at 9.8% CAGR | SNS Insider

The Contract Manufacturing and Design Services Market is projected to grow from USD 621.36 billion in 2024 to USD 1441.89 billion by 2032, driven by technological innovations like IoT, AI, and Industry 4.0, with Asia Pacific leading market expansion.

BHE JBL WXXWY contract manufacturing design services IoT AI Industry 4.0
Sentiment note

Part of leading market players in a rapidly growing industry with strong technological innovation potential

Neutral The Motley Fool • Jesterai
Benchmark (BHE) Q2 EPS Beats by 2%

Benchmark Electronics reported Q2 2025 earnings with non-GAAP EPS of $0.55, slightly beating estimates. While revenue declined year-on-year, the company achieved multi-year record bookings and saw growth in semiconductor capital equipment and aerospace & defense sectors.

BHE earnings manufacturing semiconductor aerospace electronics
Sentiment note

Mixed financial performance with slight earnings beat, record bookings, but year-on-year revenue decline and ongoing sector challenges indicate cautious outlook

Neutral GlobeNewswire Inc. • Researchandmarkets.Com
Telecom Electronic Manufacturing Services Industry 2024 - Focus on Green Manufacturing Initiatives in Telecom EMS Spurs Growth

The global Telecom Electronic Manufacturing Services (EMS) market is expected to grow from $213.4 billion in 2023 to $319.5 billion by 2030, driven by factors like increasing demand for telecom infrastructure, 5G network deployment, and the need for cost-efficient manufacturing solutions. The focus on green manufacturing initiatives in the telecom EMS industry is also contributing to market growth.

BHE CLS Telecom Electronic Manufacturing Services EMS Green Manufacturing 5G IoT
Sentiment note

The article lists Benchmark Electronics, Inc. as one of the major players in the Telecom EMS market, but does not provide any additional details about the company's performance or prospects.

Positive Benzinga • Prnewswire
BENCHMARK ELECTRONICS ANNOUNCES QUARTERLY CASH DIVIDEND

Benchmark Electronics (BHE) announced a quarterly cash dividend of $0.17 per share, payable on October 11, 2024, to shareholders of record on September 30, 2024.

BHE Benchmark Electronics dividend
Sentiment note

The company announced a quarterly cash dividend, which is generally seen as a positive sign for shareholders.

Unknown Benzinga • Avi Kapoor
Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday. Shares of Oddity Tech Ltd. (NASDAQ: ODD) fell sharply in today’s pre-market trading after the company reported worse-than-expected fourth-quarter EPS results and issued FY24 EPS guidance below estimates. ODDITY Tech posted earnings of 8 cents per share, missing market estimates of 12 cents per share. The company’s quarterly sales came in at $97.25 million versus expectations of $86.38 million, according to data from Benzinga Pro. Oddity Tech shares tumbled 10.4% to $41.10 in pre-market ...

ROST BHE EVC GRFS News Penny Stocks Small Cap Pre-Market Outlook
Unknown Benzinga • Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022

Upgrades According to Citigroup, the prior rating for Cyxtera Technologies Inc (NASDAQ:CYXT) was changed from Neutral to Buy. The current stock performance of Cyxtera Technologies shows a 52-week-high of $15.42 and a 52-week-low of $7.09. Moreover, at the end of the last trading period, the closing price was at $7.55. For Centennial Resource Development Inc (NASDAQ:CDEV), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Centennial Resource Dev had an EPS of $0.60, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $9.70 and a 52-week-low of $5.08. Centennial Resource Dev closed at $7.74 at the end of the last trading period. Wolfe Research upgraded the previous rating for Prologis Inc (NYSE:PLD) from Peer Perform to Outperform. In the second quarter, Prologis showed an EPS of $1.11, compared to $1.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $174.54 and a 52-week-low of $106.46. Prologis closed at $128.46 at the end of the last trading period. For AvalonBay Communities Inc (NYSE:AVB), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the second quarter, AvalonBay Communities showed an EPS of $2.43, compared to $1.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $259.05 and a 52-week-low of $183.35. AvalonBay Communities closed at $206.67 at the end of the last trading period. See all analyst ratings upgrades.   Downgrades For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Roth Capital downgraded the previous rating of Buy to Neutral. For the second quarter, Catalyst Pharmaceuticals had an EPS of $0.28, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $15.07 and a 52-week-low of $5.24. Catalyst Pharmaceuticals closed at $14.91 at the end of the last trading period. Truist Securities downgraded the previous rating for Aerie Pharmaceuticals Inc (NASDAQ:AERI) from Buy to Hold. For the second quarter, Aerie Pharmaceuticals had an EPS of $0.32, compared to year-ago quarter EPS of $0.84. The current stock performance of Aerie Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at ...Full story available on Benzinga.com

XPEV CPRX FHTX AVB Upgrades Downgrades Initiation Intraday Update
Unknown The Motley Fool • newsfeedback@fool.com (Motley Fool Transcribers)
Benchmark Electronics, inc (BHE) Q3 2021 Earnings Call Transcript

BHE earnings call for the period ending September 30, 2021.

BHE earningscall-transcripts
Unknown The Motley Fool • newsfeedback@fool.com (Motley Fool Transcribers)
Benchmark Electronics, inc (BHE) Q2 2021 Earnings Call Transcript

BHE earnings call for the period ending June 30, 2021.

BHE earningscall-transcripts
Unknown The Motley Fool • newsfeedback@fool.com (Motley Fool Transcribers)
Benchmark Electronics Inc (BHE) Q1 2021 Earnings Call Transcript

BHE earnings call for the period ending March 31, 2021.

BHE earningscall-transcripts
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal